Natus Sensory acquires medical technology company TheraB Medical
TheraB Medical gained FDA clearance for SnugLit in January 2026.
12 February 2026
12 February 2026
TheraB Medical gained FDA clearance for SnugLit in January 2026.
The approvals stem from the Phase III KEYNOTE-B96 trial data, which was presented at the 2025 ESMO Congress.
Following completion of enrolment, Senti Biosciences plans FDA discussions in 2026 on pivotal registration and new AML studies.
Callavid is a medical device designed to offer leak-resistant administration of vaginal medications.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.